Delivery Order SPE2DB20D9127-SPE2DB25FPPW1

Award Date 2/14/25
Potential Completion Date 3/10/25
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $29,829.40, is for the delivery of 4567090302 RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product, with a completion date of February 19, 2025. DMS Pharmaceutical Group Inc. also holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $9,207.51 firm fixed-price contract is for the delivery of 4564558204 RITUXAN 500 MG/50 ML VIAL 50ML, with a performance period through May 29, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $38,247.48 contract is for the delivery of RITUXAN 500 MG/50 ML VIAL 50ML to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business. The $31,872.90 contract is for the delivery of 4562002706 - RITUXAN 500 MG/50 ML VIAL 50ML. The order has a completion date of September 18, 2023 and is not set aside. DMS Pharmaceutical Group is a pharmaceutical wholesaler that provides a wide range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $31,872.90, is for the delivery of 4560566457 - RITUXAN 500 MG/50 ML VIAL 50ML. This order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $31,919.10 contract is for the delivery of 4557562609 - RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The contract is not associated with any set-aside designation. However, DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,383.40 contract is for the delivery of 4564604560 - RITUXAN 500 MG/50 ML VIAL 50ML, with a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999 and running...
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,383.40 contract is for the provision of 4565682754 - RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Rituxan 500 mg/50 ml vials. The award value is $6,138.34 and the ultimate completion date is June 14, 2024. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $64,785.40, is to deliver 4554632180 - RITUXAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB25FPPW1
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $29,829.40 contract is for the delivery of 4567303384 - RITUXAN 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product, with a completion date of March 10, 2025.

DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. This delivery order is issued under that broader IDC vehicle. The contract does not have a set-aside designation.

Generated 5/16/25, 12:32 PM